Position in UTHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,681,455
+$1,662,616 QoQ
Shares Held
4,522
+116.3% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FRED ALGER MANAGEMENT, LLC holds $17,745,861 across 6 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
136,254 | $10,334,865 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
4,522 | $2,681,455 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
81,865 | $2,465,773 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
123,961 | $1,180,108 | |
| 5 | ZTS |
Zoetis Inc.
|
7,305 | $863,523 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
1,671 | $220,137 |
All Filings in UTHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,681,455 | 4,522 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,018,839 | 2,091 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,786,673 | 4,262 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $256,480 | 832 | Shares | Sole | 2025-05-16 | |
| 2023-03-31 | $36,057 | 161 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $51,033,130 | 183,513 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $19,521,360 | 82,844 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||